Keytruda is a prescription medication used to treat advanced melanoma, a type of lymphoma, advanced non-small cell lung cancer, recurrent or metastatic (advanced) head and neck cancer, and patients whose cancers have a specific genetic feature. Keytruda belongs to a group of drugs called PD-1 Blockers.
Keytruda dosage. Usual adult dose for Melanoma – Metastatic: 2 mg/kg IV infusion over 30 minutes. Duration of therapy: Administer every 3 weeks until disease progression or unacceptable toxicity. Uses: Treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and a BRAF inhibitor if BRAF V600 mutation positive.